NCT03616600

Brief Summary

In Hong Kong, approximately 80% of children are myopic by the end of childhood. There is intense interest currently in the potential role of peripheral defocus as a clinical treatment to slow myopia progression. One of the most successful treatments for myopia is orthokeratology. Currently, Breath-O correct lenses are new designed ready-made orthokeratology lenses. This study is to evaluate the safety of wearing this new orthokeratology lens and the effectiveness of clinical performance in young adult.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

March 15, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 6, 2018

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2019

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

April 13, 2020

Completed
Last Updated

February 10, 2021

Status Verified

January 1, 2021

Enrollment Period

6 months

First QC Date

March 15, 2018

Results QC Date

March 11, 2019

Last Update Submit

January 26, 2021

Conditions

Keywords

MyopiaOrthokeratology

Outcome Measures

Primary Outcomes (5)

  • Corneal Biomechanics in Terms of Corneal Hysteresis and Resistance Factor

    measured by ocular response analyser

    Baseline, 1st Month, 3rd Month

  • Corneal Endothelial Health in Terms of Endothelial Cell Density

    measured by specular microscope

    Baseline, 1st Month, 3rd Month

  • Corneal Endothelial Health in Terms of Percentage of Variation in Cell Size

    measured by specular microscope

    Baseline, 1st Month, 3rd Month

  • Anterior Ocular Health in Terms of Limbal and Bulbar Redness

    measured by OCULUS Keratograph® 5M and graded by JENVIS redness grading system It is a scale of 0 to 4, the higher the score, the more redness the ocular surface manifests

    Baseline, 1st Month, 3rd Month

  • Anterior Ocular Surface Evaluation in Terms of Non-invasive Keratography Break-up Time (NIKBUT)

    measured by OCULUS Keratograph® 5M

    Baseline, 1st Month, 3rd Month

Secondary Outcomes (2)

  • Best Corrected Visual Acuity in Terms of High and Low Contrast

    Baseline, 1st Month and the 3rd Month

  • Reduction of the Refractive Power After Wearing the Breath-O-correct Lens

    Baseline, 1st Week, 1st Month, 3rd Month

Study Arms (2)

Treatment

EXPERIMENTAL

Wearing the orthokeratology lenses for 3 months

Other: Breath-O-Correct Lens

Control

NO INTERVENTION

Not wearing any contact lenses

Interventions

Breath-O correct lenses are new designed ready-made orthokeratology lenses which are made of new material with more elasticity as compared traditional lens material

Treatment

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Refractive error: Spherical: normally -1.00D to -4.00D (maximum up to -5.00D); Cylindrical: normally half of Sph (against-the-rule Astigmatism.: lower than -0.75D) (maximum up to -1.50D)
  • Best corrected Visual acuity: monocular ETDRS 0.0 or better
  • Ocular health: No ocular abnormality, no contra-indications for overnight orthokeratology lens wear, no refractive surgery
  • General health: No systemic diseases
  • Requirement: No history of orthokeratology lens wearing. Agree to participate in this study and willing to wear the orthokeratology lenses overnight in accordance with the instructions given and to come back for follow up within the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Dr. Henry Chan
Organization
Hong Kong Polytechnic University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assocaite Professor

Study Record Dates

First Submitted

March 15, 2018

First Posted

August 6, 2018

Study Start

March 1, 2018

Primary Completion

August 31, 2018

Study Completion

January 15, 2019

Last Updated

February 10, 2021

Results First Posted

April 13, 2020

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations